Plozalizumab Explained

Plozalizumab (INN; hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency.[1] [2]

This drug was developed by Takeda Pharmaceuticals International Co.

References

  1. http://www.ama-assn.org/resources/doc/usan/x-pub/plozalizumab.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Plozalizumab
  2. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113 . WHO Drug Information . 29 . 2 . 2015 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Plozalizumab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.